Patching adherence is linked to improved grating visual acuity

Article

Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract.

Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract, reveals a paper in Investigative Ophthalmology & Visual Science.

Dr Carolyn D. Drews-Botsch et al., Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA, completed a randomized clinical trial of 108 infants with unilateral congenital cataract.

Patching was conducted one hour per day every month until the patient was eight months of age. The mean percentage of prescribed patching was used to measure adherence in a weeklong diary completed two months postoperatively. Recall interviews lasting 48 hours were also performed three and six months postoperatively.

Teller Acuity Cards were used to measure grating visual acuity within one month of the infant's first birthday. The link between grating acuity and patching was found with nonparametric correlations.

The results revealed that 84.3% of prescribed time and adherence did not change according to treatment. Adherence was found to be strongly associated with grating acuity, especially among pseudophakic patients compared to aphakic infants. Implanting an intraocular lens (IOL) was not linked to adherence.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.